Compare KZR & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KZR | ICCM |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.5M | 43.4M |
| IPO Year | 2018 | 2013 |
| Metric | KZR | ICCM |
|---|---|---|
| Price | $6.75 | $0.58 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $6.00 | $2.50 |
| AVG Volume (30 Days) | 44.5K | ★ 175.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $19.87 |
| Revenue Next Year | N/A | $31.38 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.53 | $0.54 |
| 52 Week High | $6.86 | $1.53 |
| Indicator | KZR | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 69.05 | 42.42 |
| Support Level | $6.06 | $0.54 |
| Resistance Level | N/A | $0.74 |
| Average True Range (ATR) | 0.18 | 0.03 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 85.62 | 26.94 |
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.